George Panos

Summary

Affiliation: University of Patras School of Medicine, Patras University General Hospital
Location: Patras, Greece
Summary:
Assistant Professor in Internal Medicine & Infectious Diseases

Internal Medicine
Infectious Diseases
Including:
Tropical Medicine
HIV Medicine
Hepatitis
Biomedical Engineering and Computing

Publications

  1. doi request reprint Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata
    Joanne Reekie
    University College London Medical School, London, UK
    AIDS 25:2259-68. 2011
  2. pmc Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study
    Rebecca K Lodwick
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, Royal Free Campus, London, UK
    Lancet 376:340-5. 2010
  3. doi request reprint Effect of meteorological variables on the incidence of respiratory tract infections
    Matthew E Falagas
    Alfa Institute of Biomedical Sciences AIBS, Athens, Greece
    Respir Med 102:733-7. 2008
  4. doi request reprint Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece
    George Panos
    HIV Unit, 1st IKA Hospital, Athens, Greece
    AIDS Res Hum Retroviruses 24:43-51. 2008
  5. pmc Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials
    Dimitrios K Matthaiou
    Alfa Institute of Biomedical Sciences AIBS, Athens, Greece
    PLoS Negl Trop Dis 2:e194. 2008
  6. pmc Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen
    Zoe Fox
    Copenhagen HIV Programme, University of Copenhagen Rigshospitalet, Copenhagen, Denmark
    AIDS 22:2279-89. 2008
  7. doi request reprint Loss to follow-up in an international, multicentre observational study
    A Mocroft
    Royal Free and University College Medical School, London, UK
    HIV Med 9:261-9. 2008
  8. pmc Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction
    C A Sabin
    Dept of Primary Care and Population Sciences, Royal Free and UC Medical School, Rowland Hill St, London, NW3 2PF, United Kingdom
    Clin Infect Dis 46:1101-10. 2008
  9. ncbi request reprint Mortality and morbidity of HIV infected patients receiving HAART: a cohort study
    George Panos
    HIV Unit, 1st IKA Hospital, Athens, Greece
    Curr HIV Res 6:257-60. 2008
  10. doi request reprint Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study
    Sean Emery
    Therapeutic and Vaccine Research Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria St, Sydney, NSW 2010, Australia
    J Infect Dis 197:1133-44. 2008

Collaborators

Detail Information

Publications62

  1. doi request reprint Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata
    Joanne Reekie
    University College London Medical School, London, UK
    AIDS 25:2259-68. 2011
    ..9  copies/ml) and high (≥ 10000  copies/ml)...
  2. pmc Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study
    Rebecca K Lodwick
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, Royal Free Campus, London, UK
    Lancet 376:340-5. 2010
    ..We aimed to examine this by analysis of pooled data from industrialised countries...
  3. doi request reprint Effect of meteorological variables on the incidence of respiratory tract infections
    Matthew E Falagas
    Alfa Institute of Biomedical Sciences AIBS, Athens, Greece
    Respir Med 102:733-7. 2008
    ..The possible effect of the various meteorological variables on the incidence of upper and lower respiratory tract infections (RTIs) has intrigued the scientific community for decades...
  4. doi request reprint Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece
    George Panos
    HIV Unit, 1st IKA Hospital, Athens, Greece
    AIDS Res Hum Retroviruses 24:43-51. 2008
    ..M184V (63.6%) and K103N (25.2%) were the most frequent mutations related to NRTIs and NNRTIs, respectively...
  5. pmc Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials
    Dimitrios K Matthaiou
    Alfa Institute of Biomedical Sciences AIBS, Athens, Greece
    PLoS Negl Trop Dis 2:e194. 2008
    ..We investigated the role of albendazole and praziquantel in the treatment of patients with parenchymal neurocysticercosis by performing a meta-analysis of comparative trials of their effectiveness and safety...
  6. pmc Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen
    Zoe Fox
    Copenhagen HIV Programme, University of Copenhagen Rigshospitalet, Copenhagen, Denmark
    AIDS 22:2279-89. 2008
    ..Limited data exist to guide clinical practice on the best interruption strategy to use...
  7. doi request reprint Loss to follow-up in an international, multicentre observational study
    A Mocroft
    Royal Free and University College Medical School, London, UK
    HIV Med 9:261-9. 2008
    ..The aim of this work was to assess loss to follow-up (LTFU) in EuroSIDA, an international multicentre observational cohort study...
  8. pmc Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction
    C A Sabin
    Dept of Primary Care and Population Sciences, Royal Free and UC Medical School, Rowland Hill St, London, NW3 2PF, United Kingdom
    Clin Infect Dis 46:1101-10. 2008
    ..We evaluated changes in risk factors for CVD and the use of lipid-lowering therapy in HIV-infected individuals and assessed the impact of any changes on the incidence of myocardial infarction...
  9. ncbi request reprint Mortality and morbidity of HIV infected patients receiving HAART: a cohort study
    George Panos
    HIV Unit, 1st IKA Hospital, Athens, Greece
    Curr HIV Res 6:257-60. 2008
    ..Our data from the studied cohort adds to the relevant literature regarding the dramatic reduction of morbidity and mortality that occurred after the availability of HAART...
  10. doi request reprint Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study
    Sean Emery
    Therapeutic and Vaccine Research Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria St, Sydney, NSW 2010, Australia
    J Infect Dis 197:1133-44. 2008
    ..In the DC group, participants started ART when the CD4+ cell count was <250 cells/microL. Clinical outcomes in participants not receiving ART at entry inform the early use of ART...
  11. doi request reprint Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
    Nina Friis-Møller
    Copenhagen HIV Programme CHIP, University of Copenhagen Faculty of Health Science, Copenhagen, Denmark
    Eur J Cardiovasc Prev Rehabil 17:491-501. 2010
    ..Furthermore, exposures to some antiretroviral drugs seem to be independently associated with increased CVD risk. We aimed to develop cardiovascular risk-assessment models tailored to HIV-infected patients...
  12. doi request reprint Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study
    Wendy P Bannister
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, United Kingdom
    J Acquir Immune Defic Syndr 48:324-33. 2008
    ..To investigate prevalence of transmitted drug-resistant human immunodeficiency virus (TDR) and factors associated with TDR and to compare virological and CD4 count response to combination antiretroviral therapy...
  13. doi request reprint Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART
    Daria Podlekareva
    Copenhagen HIV Programme, University of Copenhagen, Faculty of Health Sciences, Denmark
    Scand J Infect Dis 40:908-13. 2008
    ..FI can be used as a clinical marker for disease progression and indirect indicator for initiation/changing cART in settings where laboratory facilities are limited...
  14. doi request reprint Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
    Amanda Mocroft
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, Division of Population Health, University College London Medical School, Royal Free Campus, London, UK
    AIDS 24:1667-78. 2010
    ..Chronic kidney disease (CKD) in HIV-positive persons might be caused by both HIV and traditional or non-HIV-related factors. Our objective was to investigate long-term exposure to specific antiretroviral drugs and CKD...
  15. pmc Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
    Caroline A Sabin
    Lancet 371:1417-26. 2008
    ..Our aim was to explore whether exposure to such drugs was associated with an excess risk of myocardial infarction in a large, prospective observational cohort of HIV-infected patients...
  16. ncbi request reprint Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial
    W M El-Sadr
    Ann Intern Med 149:289-99. 2008
    ..Episodic use of antiretroviral therapy guided by CD4+ cell counts is inferior to continuous antiretroviral therapy...
  17. doi request reprint Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?
    Joanne Reekie
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, Royal Free and University College Medical School, London, UK
    AIDS 22:2381-90. 2008
    ..To investigate whether HIV-infected patients on a stable and fully suppressive combination antiretroviral therapy (cART) regimen could safely be monitored less often than the current recommendations of every 3 months...
  18. doi request reprint Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings
    Alessandro Cozzi-Lepri
    Research Department of Infection and Population Health, Royal Free and University College Medical School, London, United Kingdom
    J Infect Dis 200:687-97. 2009
    ....
  19. ncbi request reprint Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?
    G Z Panos
    Alfa Institute of Biomedical Sciences AIBS, Athens, Greece
    Aliment Pharmacol Ther 24:731-42. 2006
    ..Escherichia coli O157:H7 is a foodborne pathogen causing haemorrhagic colitis, which is sometimes complicated by haemolytic uraemic syndrome or thrombotic thrombocytopenic purpura...
  20. doi request reprint A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy
    Roger Paredes
    Institut de Recerca de la SIDA IrsiCaixa, Spain
    J Infect Dis 204:741-52. 2011
    ..The clinical relevance of mutations in the connection subdomain and the ribonuclease (RNase) H domain of HIV-1 reverse transcriptase (RT) is uncertain...
  21. ncbi request reprint Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression
    Lars Peters
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    J Acquir Immune Defic Syndr 50:457-63. 2009
    ..Conflicting data exist whether hepatitis C virus (HCV) affects the CD4 cell recovery in patients with HIV starting antiretroviral treatment...
  22. ncbi request reprint Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study
    E Florence
    Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
    HIV Med 4:255-62. 2003
    ..To describe the prevalence and risk factors of poor CD4 count rise despite a good virological response on highly active antiretroviral treatment (HAART)...
  23. ncbi request reprint Multi-skeletal Pneumocystis jiroveci (carinii) in an HIV-seropositive patient
    George Z Panos
    1st IKA Hospital, Penteli, Athens, Greece
    Int J STD AIDS 18:134-7. 2007
    ..jiroveci infection in an HIV-seropositive patient, with multiple skeletal lesions, especially in the skull and in vertebrae region, and concomitant non-small-cell lung cancer, with a very poor prognosis...
  24. ncbi request reprint Helicobacter pylori infection in symptomatic HIV-seropositive and -seronegative patients: a case-control study
    George Z Panos
    First IKA Hospital, Athens, Greece
    AIDS Res Hum Retroviruses 23:709-12. 2007
    ..06). The grading of the density of H. pylori infection and the grading of the histomorphological findings according to the Sydney classification were similar between HIV-seropositive and -seronegative patients with H. pylori infection...
  25. ncbi request reprint Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts
    Amanda Mocroft
    Royal Free and University College Medical School, London, UK
    Antivir Ther 12:325-33. 2007
    ....
  26. doi request reprint High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    AIDS 24:427-35. 2010
    ....
  27. ncbi request reprint Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting
    J Gold
    The Albion Street Centre, Surry Hills, NSW, Australia
    HIV Med 7:146-55. 2006
    ..Nandrolone decanoate treatment resulted in greater increases in fat-free mass than placebo and demonstrated a trend for a significant increase when compared with testosterone...
  28. doi request reprint A meta-analysis of transient elastography for the detection of hepatic fibrosis
    Justin Stebbing
    Department of HIV Medicine, Chelsea and Westminster Hospital, St Stephen s Centre, Imperial College School of Medicine, London, UK
    J Clin Gastroenterol 44:214-9. 2010
    ..We performed a meta-analysis to further assess its use in comparison with liver biopsy...
  29. doi request reprint Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe
    Vincent Soriano
    Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain
    J Antimicrob Chemother 65:548-55. 2010
    ..Information about factors determining HBV genotype distribution and viraemia in HIV/HBV-co-infected patients is scarce...
  30. doi request reprint History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change
    J Reekie
    Research Department of Infection and Population Health, University College London Medical School, UK
    HIV Med 11:469-78. 2010
    ..The relationship between such differences and risk of virological failure after starting a new antiretroviral could help with patient monitoring strategies...
  31. doi request reprint Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet
    E D Lagadinou
    Department of Internal Medicine, Patras University Medical Center, Rio Patras, Greece
    Transpl Infect Dis 12:437-40. 2010
    ..Late bone marrow aplasia and late severe infections after allo-HCT without other obvious causes may be HHV-6 related...
  32. doi request reprint Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies
    Joanne Reekie
    University College London Medical School, London, UK
    Cancer 116:5306-15. 2010
    ..However, conflicting data have been reported on the relationship between immunodeficiency and the development of some non-AIDS-defining malignancies...
  33. doi request reprint Serious fatal and nonfatal non-AIDS-defining illnesses in Europe
    Amanda Mocroft
    Research Department of Infection and Population Health, University College Medical School, London, UK
    J Acquir Immune Defic Syndr 55:262-70. 2010
    ..Little is known about the incidence and risk factors for serious non-AIDS-defining events...
  34. doi request reprint Dialysis and renal transplantation in HIV-infected patients: a European survey
    Joan Carles Trullàs
    Department of Internal Medicine, Hosp Sant Jaume, Olot, Girona, Spain
    J Acquir Immune Defic Syndr 55:582-9. 2010
    ..To determine prevalence and characteristics of end-stage renal diseases (ESRD) [dialysis and renal transplantation (RT)] among European HIV-infected patients...
  35. doi request reprint A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study
    J Reekie
    Research Department of Infection and Population Health, University College London Medical School, Royal Free Campus, London, UK
    HIV Med 12:259-68. 2011
    ..The aim of this analysis was to compare the durability of nevirapine, efavirenz and lopinavir regimens based on these measures...
  36. doi request reprint A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study
    Justyna D Kowalska
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    HIV Clin Trials 12:109-17. 2011
    ....
  37. ncbi request reprint Dealing with the substance abuse epidemic and infective endocarditis: clinical, immunologic and pathogenetic aspects
    Ioannis Starakis
    Department of Internal Medicine, Patras University Hospital
    Curr Vasc Pharmacol 10:247-56. 2012
    ..Our aim is to comprehensively review the clinical features and complications and also the possible pathogenetic and immunologic mechanisms implicated in IE patients who are injecting illicit substances...
  38. doi request reprint Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy
    Justyna D Kowalska
    Copenhagen HIV Programme, University of Copenhagen, Denmark
    AIDS 26:315-23. 2012
    ..Therefore we investigated changes in the rate of death with increasing exposure to cART...
  39. pmc Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection
    Alison J Rodger
    HIV Epidemiology and Biostatistics Group, Research Dept of Infection and Population Health, UCL Medical School, University College London, London, UK
    J Infect Dis 200:973-83. 2009
    ..Their associations with opportunistic disease (OD) in human immunodeficiency virus (HIV)-positive patients were examined...
  40. ncbi request reprint Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin
    Dimitrios Paraskevis
    Department of Hygiene and Epidemiology, National Retrovirus Reference Center, Athens, Greece
    J Infect Dis 196:1167-76. 2007
    ..In North America and Europe, human immunodeficiency virus (HIV)-1 infection has typically been dominated by subtype B transmission. More recently, however, non-B subtypes have been increasingly reported in Europe...
  41. ncbi request reprint Infectious disease cases for educational purposes: open-access resources on the Internet
    Matthew E Falagas
    Alfa Institute of Biomedical Sciences, 1st IKA Hospital, Athens, Greece
    Clin Infect Dis 45:495-500. 2007
    ....
  42. ncbi request reprint Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation
    George Z Panos
    J Clin Gastroenterol 41:222-3. 2007
  43. ncbi request reprint Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review
    Matthew E Falagas
    Alfa Institute of Biomedical Sciences AIBS, 9 Neapoleos St, 151 23 Marousi, Athens, Greece
    Mayo Clin Proc 81:1567-74. 2006
    ..To systematically examine the available evidence regarding the effect of initial discordant therapy with beta-lactam antibiotics on mortality, clinical success, and bacteriological eradication in patients with pneumococcal pneumonia...
  44. ncbi request reprint Implications of findings of bibliometric analyses in parasitology
    Matthew E Falagas
    Trends Parasitol 23:12-3. 2007
  45. ncbi request reprint Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece
    D Paraskevis
    Department of Hygiene and Epidemiology, Athens University Medical School, Mikras Asias 75, GR 11527 Athens, Greece
    Virus Res 112:115-22. 2005
    ..For two individuals, there was clear evidence for transmitted resistance based on epidemiological information for a known source of HIV-1 transmission. The prevalence of the HIV-1 non-B subtypes and recombinants was 52%...
  46. ncbi request reprint Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study
    Ulrik Bak Dragsted
    Hvidovre University Hospital, Copenhagen, Denmark
    J Infect Dis 190:148-55. 2004
    ..Factors that determine the immunological response to highly active antiretroviral therapy (HAART) are poorly defined...
  47. ncbi request reprint The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study
    Colette J Smith
    Royal Free and University College Medical School, London, UK
    AIDS 22:47-56. 2008
    ..This study investigated the incidence of pancreatitis and its association with antiretroviral therapy (ART), focussing on stavudine and didanosine...
  48. pmc Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature
    Matthew E Falagas
    Alfa Institute of Biomedical Sciences AIBS, Athens, Greece
    Retrovirology 5:13. 2008
    ..Thus, we sought to perform a systematic review of the evidence regarding the association of SES with adherence to treatment of patients with HIV/AIDS...
  49. pmc Interruption of antiretroviral therapy is associated with increased plasma cystatin C
    Amanda Mocroft
    University College London Medical School, London, UK
    AIDS 23:71-82. 2009
    ....
  50. ncbi request reprint The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results
    Daria Podlekareva
    Copenhagen HIV Programme, University of Copenhagen, Denmark
    Cent Eur J Public Health 16:99-105. 2008
    ..Strategies include creating scientific collaborations for HIV clinicians as well as teaching clinicians about the most advanced HIV management at clinically oriented courses held in eastern Europe...
  51. pmc HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies
    Antonella D arminio Monforte
    Dipartimento di Medicina, Chirurgia e Odontoiatria, Clinica di Malattie Infettive e Tropicali, Azienda Ospedaliera Polo Universitario San Paolo, via A Di Rudinì 8 20142 Milano, Italy
    AIDS 22:2143-53. 2008
    ..To evaluate deaths from AIDS-defining malignancies (ADM) and non-AIDS-defining malignancies (nADM) in the D:A:D Study and to investigate the relationship between these deaths and immunodeficiency...
  52. doi request reprint Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe
    Vincent Soriano
    Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain
    J Infect Dis 198:1337-44. 2008
    ....
  53. ncbi request reprint Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity
    George Panos
    HIV Unit, 2nd Internal Medicine Clinic, 1st IKA Hospital, Athens, Greece
    Am J Hematol 82:761-5. 2007
    ..The patient remains in complete remission 61 months after the diagnosis of plasmablastic lymphoma...
  54. doi request reprint Transient elastography, liver stiffness values, and acute hepatopathy
    George Panos
    Hepatology 47:2140; author reply 2141. 2008
  55. doi request reprint Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up
    Jens D Lundgren
    Copenhagen HIV Programme CHIP, Faculty of Health Sciences, University of Copenhagen, Panum Institute, 2200 Copenhagen N, Denmark
    J Infect Dis 197:1145-55. 2008
    ..Rates and predictors of opportunistic disease or death (OD/death) and the relative risk (RR) in DC versus VS groups according to the latest CD4+ cell count and HIV RNA level are reported...
  56. ncbi request reprint Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study
    J P Viard
    Service d immunologie clinique, Hopital Necker Enfants Malades, 149 rue de Sevres, 75743 Paris Cedex 15, Paris, France
    J Infect Dis 183:1290-4. 2001
    ..Time to a CD4 increase of >200x106 cells/L was shorter for patients in the younger age groups (P=.0026), as confirmed by multivariate analysis (P<10-4). Younger age may favor CD4 cell restoration because of preserved thymic function...